# Renbio, Inc.

Canonical: https://abierto.us/vendors/renbio-inc-nmyhcdqn7dr3

- UEI: NMYHCDQN7DR3
- CAGE: 7K9J1
- Location: Long Island City, NY
- Awards in window: 1 (4 transactions), $749,289 obligated, April 29, 2024 to May 22, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $749,289

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $749,289

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50124C00017 (definitive contract): $749,289, Barda - Aspr / Daappo / Barda DCMA. Renbio INC. - Aoi#25(Fastx) R&D for Myo Technology for DNA-BASED Delivery of Anti-Influenza Antibodies to Large Animals. https://www.usaspending.gov/award/CONT_AWD_75A50124C00017_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/renbio-inc-nmyhcdqn7dr3.